Abstract:BackgroundOsteoarthritis (OA) is a debilitating joint disorder characterized by progressive cartilage degeneration. During OA, subchondral bone undergoes microstructural and molecular changes that precede cartilage degradation. However, specific mechanisms underlying metabolic dysregulation of the bone-cartilage unit remain unclear. This study aims to investigate the role of receptor-interacting protein kinase-3 (RIP3) in OA progression, focusing on bone-cartilage metabolic homeostasis.MethodsRIP3-mediated pathological and metabolic alterations in chondrocytes, osteoblasts, and bone marrow-derived macrophages (BMMs) were evaluated. RIP3-mediated OA manifestations in cartilage and more importantly, subchondral bone were determined by intra-articular overexpression of RIP3 in rats. The protective effect of RIP3 deficiency on the bone-cartilage unit during OA was systematically investigated using Rip3 knockout mice. The CMap database was used to screen for compounds that abrogate RIP3-induced OA pathological changes.ResultsRIP3 was upregulated in the cartilage and subchondral bone of OA patients and post-traumatic OA mouse model. RIP3 overexpression not only inhibited extracellular matrix (ECM) anabolism in chondrocytes but also attenuated osteoblast differentiation, whereas RIP3 deficiency blunted receptor activator of NF-kappaB ligand-mediated osteoclastogenesis of BMMs. Intra-articular RIP3 overexpression induced the imbalance of SP7+ osteoblasts/tartrate-resistant acid phosphatase (TRAP)+ osteoclasts within the subchondral bone in addition to cartilage degeneration in rats, while Rip3 deletion significantly improved structural outcomes of the bone-cartilage unit, and achieved pain relief as well as functional improvement in surgery-induced and spontaneous OA mouse models. Mechanistically, RIP3 initiates OA by perturbing critical events, including cartilage metabolism, inflammatory responses, senescence, and osteoclast differentiation. Clofibrate, a hypolipidemic drug, was identified as a novel RIP3 inhibitor that reverses ECM catabolism in OA.ConclusionsRIP3 is an essential governor of whole joint metabolic homeostasis by regulating both cartilage metabolism and subchondral bone remodeling. Reconstruction of the bone-cartilage unit by targeting RIP3 might provide a two-birds-one-stone approach for the development of future OA therapies.

RIP2 knockdown inhibits cartilage degradation and oxidative stress in IL-1β-treated chondrocytes via regulating TRAF3 and inhibiting p38 MAPK pathway

Decreased RIPK1 Expression in Chondrocytes Alleviates Osteoarthritis Via the TRIF/MyD88-RIPK1-TRAF2 Negative Feedback Loop

Reciprocal Inhibition of YAP/TAZ and NF-κB Regulates Osteoarthritic Cartilage Degradation

RIP1 inhibition reduces chondrocyte apoptosis through downregulating nuclear factor-kappa B signaling in a mouse osteoarthritis model

Targeting RIP3 Inhibits Osteoarthritis Development by Restoring Anabolic-Catabolic Balance in the Bone-Cartilage Unit

RIP1 Perturbation Induces Chondrocyte Necroptosis and Promotes Osteoarthritis Pathogenesis via Targeting BMP7

The pro-inflammatory effect of NR4A3 in osteoarthritis

TRIM38 Protects Chondrocytes from IL-1β-induced Apoptosis and Degeneration Via Negatively Modulating Nuclear Factor (Nf)-Κb Signaling.

The Elevated Expression of IL-38 Serves As an Anti-Inflammatory Factor in Osteoarthritis and Its Protective Effect in Osteoarthritic Chondrocytes.

Inhibition of Nuclear Receptor RORα Attenuates Cartilage Damage in Osteoarthritis by Modulating IL-6/STAT3 Pathway

Resveratrol inhibits the expression of inflammatory cytokines in cartilage cells through NF-κB signaling pathway

Knockdown Of Trem-1 Suppresses Il-1 Beta-Induced Chondrocyte Injury Via Inhibiting The Nf-Kappa B Pathway

PR11‐364P22.2/ATF3 Protein Interaction Mediates IL‐1β‐induced Catabolic Effects in Cartilage Tissue and Chondrocytes

The Specific RIP1 Inhibitor Necrostatin-1 Ameliorated Degradation of ECM in Human SW1353 Cells

Inhibition of TRADD Ameliorates Chondrocyte Necroptosis and Osteoarthritis by Blocking RIPK1-TAK1 Pathway and Restoring Autophagy.

Knockdown of TREM-1 suppresses IL-1β-induced chondrocyte injury via inhibiting the NF-κB pathway.

PDLIM2 Protects Articular Chondrocytes from Lipopolysaccharide-Induced Apoptosis, Degeneration and Inflammatory Injury Through Down-Regulation of Nuclear Factor (Nf)-Κb Signaling

Rapamycin protects chondrocytes against IL-18-induced apoptosis and ameliorates rat osteoarthritis

Downregulation of IRAK3 by miR-33b-3p relieves chondrocyte inflammation and apoptosis in an <i>in vitro</i> osteoarthritis model

TRIM59 Attenuates IL-1β-driven Cartilage Matrix Degradation in Osteoarthritis Via Direct Suppression of NF-κB and JAK2/STAT3 Signaling Pathway.

Knockdown of PRMT1 Suppresses IL-1β-induced Cartilage Degradation and Inflammatory Responses in Human Chondrocytes Through Gli1-mediated Hedgehog Signaling Pathway